VTR Stock Recent News
VTR LATEST HEADLINES
Not all REITs are worth buying. It is a vast and versatile sector with great opportunities and value traps. Here are 2 REITs that I would sell and 2 better alternatives.
Ventas' (VTR) Q4 results outshine estimates on better-than-anticipated revenues. The same-store NOI improves across the portfolio.
Ventas, Inc.'s senior housing operating portfolio showed strong performance in Q4 2023, with net operating income up 15%. The 2024 guidance for Ventas was weaker than expected. We examine our earlier call of only buying in the low $30s and tell you why we are sticking to it.
While the top- and bottom-line numbers for Ventas (VTR) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Ventas (VTR) came out with quarterly funds from operations (FFO) of $0.76 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.73 per share a year ago.
Favorable SHOP operating trends, healthy demand for life-science real estate assets and accretive investments are likely to have benefited Ventas' (VTR) Q4 earnings.
Ventas (VTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Get a deeper insight into the potential performance of Ventas (VTR) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its fourth quarter 2023 earnings release after the close of trading on the New York Stock Exchange on Wednesday, February 14, 2024. A conference call to discuss those earnings will be held on Thursday, February 15, 2024 at 1:00 p.m. Eastern Time (12:00 p.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webca.
A rise in healthcare spending by senior citizens and accretive investments in the research portfolio bode well for Ventas (VTR). However, dependence on a few tenants and high interest rates are woes.